Key result
HbA1C reflects average blood glucose over ~11 weeks to guide diabetes treatment decisions.
Why the study?
HbA1C has become the gold-standard measurement of chronic glycaemia and is widely used to guide treatment decisions, but an overview of its clinical relevance and usefulness is needed.
The HbA1c test remains the gold-standard measurement for chronic glycemia, guiding clinical treatment decisions and predicting long-term complication risks in diabetes.
The hemoglobin A1C (HbA1C) assay has become the gold-standard measurement of chronic glycaemia for over two decades. It provides an average blood glucose level during the preceding 10 - 12 weeks. Its close association with risk for long-term complications, established in epidemiologic studies and clinical trials, has resulted in clinicians using HbA1C test results to guide their treatment decisions, and thus the assay has become the cornerstone of clinical practice. This brief review describes some important facts about HbA1C and its relevance and usefulness in clinical practice. DOI: http://dx.doi.org/10.4038/sjdem.v3i2.6379 Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2013; 3 : 104-107
No takes yet. Share an insight, caveat, or question.
Pathmanathan et al. (2014) conducted a review in Diabetes. Hemoglobin A1C (HbA1C) assay was evaluated. The hemoglobin A1C (HbA1C) assay provides an average blood glucose level during the preceding 10-12 weeks and serves as the gold-standard measurement for guiding treatment decisions in diabetes.
Synapse has enriched 5 related papers. Consider them for comparative context: